The Pharmacological Treatment of Pediatric Vertigo

Vertigo in children is a challenging topic. The lack of dedicated trials, guidelines and papers causes inhomogeneity in the treatment of vertigo in children. Meniere's disease, migraine equivalents, vestibular neuritis, paroxysmal positional benign vertigo (BPPV), persistent postural-perceptual...

Full description

Saved in:
Bibliographic Details
Published in:Children (Basel) 2022-04, Vol.9 (5), p.584
Main Authors: Viola, Pasquale, Marcianò, Gianmarco, Casarella, Alessandro, Pisani, Davide, Astorina, Alessia, Scarpa, Alfonso, Siccardi, Elena, Basile, Emanuele, De Sarro, Giovambattista, Gallelli, Luca, Chiarella, Giuseppe
Format: Article
Language:English
Subjects:
Adults
Ataxia
children
Citation management software
Disease prevention
dizziness
Drugs
Head injuries
Headaches
Migraine
pediatric
Pediatrics
Review
Vertigo
vestibular
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Vertigo in children is a challenging topic. The lack of dedicated trials, guidelines and papers causes inhomogeneity in the treatment of vertigo in children. Meniere's disease, migraine equivalents, vestibular neuritis, paroxysmal positional benign vertigo (BPPV), persistent postural-perceptual dizziness (PPPD) and motion sickness may affect children with various degrees of incidence and clinical severity compared to adults. Several drugs are proposed for the management of these conditions, even if their use is subordinated to the child's age. In this review, we summarize the existing evidence related to the use of drugs for this clinical condition in children as a start point for new trials, stating the urgent need for international guidelines.
ISSN:2227-9067
2227-9067
DOI:10.3390/children9050584